Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease

American Journal of Pathology

Volumn 181, Issue 1, 2012, Pages 130-140

  Esper, Lisia ^a   Roman Campos, Danilo ^a   Lara, Aline ^a   Brant, Fatima ^a   Castro, Luisa L ^a   Barroso, Andreia ^a   Araujo, Ronan Ricardo S ^a   Vieira, Leda Q ^a,b   Mukherjee, Shankar ^c   Gomes, Eneas Ricardo M ^a   Rocha, Nazareth N ^d   Ramos, Isalira P R ^d   Lisanti, Michael P ^e   Campos, Camila F ^a   Arantes, Rosa M E ^a   Guatimosim, Silvia ^a   Weiss, Louis M ^c   Cruz, Jader Santos ^a   Tanowitz, Herbert B ^c   Teixeira, Mauro M ^a   Machado, Fabiana S ^a   more..

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LIPOXIN A; POTASSIUM; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CHAGAS DISEASE; CONTROLLED STUDY; HEART FUNCTION; HEART INJURY; HEART MUSCLE CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PARASITEMIA; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; TRYPANOSOMA CRUZI; WAVEFORM;

ACUTE DISEASE; ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CELLS, CULTURED; CHAGAS CARDIOMYOPATHY; CYTOKINES; DISEASE MODELS, ANIMAL; HEART; LIPOXINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; PARASITE LOAD; PARASITEMIA; PATCH-CLAMP TECHNIQUES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTE SUBSETS; TRYPANOSOMA CRUZI;

EID: 84862669208     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.03.042     Document Type: Article

References (41)

1. Morris SA, Tanowitz HB, Wittner M, Bilezikian JP: Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 1990, 82:1900-1909
2. Huang H, Calderon TM, Berman JW, Braunstein VL, Weiss LM, Wittner M, Tanowitz HB: Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun 1999, 67:5434-5440
3. Mukherjee S, Huang H, Petkova SB, Albanese C, Pestell RG, Braunstein VL, Christ GJ, Wittner M, Lisanti MP, Berman JW, Weiss LM, Tanowitz HB: Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun 2004, 72:5274-5282
4. Tanowitz HB, Gumprecht JP, Spurr D, Calderon TM, Ventura MC, Raventos-Suarez C, Kellie S, Factor SM, Hatcher VB, Wittner M, Berman J: Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J Infect Dis 1992, 166:598-603
5. Tanowitz HB, Kaul DK, Chen B, Morris SA, Factor SM, Weiss LM, Wittner M: Compromised microcirculation in acute murine Trypanosoma cruzi infection. J Parasitol 1996, 82:124-130
6. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV: Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123
7. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG: Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992, 175:169-174
8. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FQ: Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995, 63:4862-4867
9. Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Carlier Y: Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 1991, 146:3626-3632
10. Almeida IC, Gazzinelli RT: Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J Leukoc Biol 2001, 70:467-477
11. Shoda LK, Kegerreis KA, Suarez CE, Roditi I, Corral RS, Bertot GM, Norimine J, Brown WC: DNA from protozoan parasites Babesia bovis. Trypanosoma cruzi, and T brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide. Infect Immun 2001, 69:2162-2171
12. Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazzinelli RT: Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol 1997, 158:5890-5901
13. Cardillo F, Voltarelli JC, Reed SG, Silva JS: Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 1996, 64:128-134
14. Silva JS, Twardzik DR, Reed SG: Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med 1991, 174:539-545
15. Rico-Bautista E, Flores-Morales A, Fernandez-Perez L: Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 2006, 17:431-439
16. Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN, Aliberti J: Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 2006, 12:330-334
17. Tannahill GM, Elliott J, Barry AC, Hibbert L, Cacalano NA, Johnston JA: SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol Cell Biol 2005, 25:9115-9126
18. Knosp CA, Carroll HP, Elliott J, Saunders SP, Nel HJ, Amu S, Pratt JC, Spence S, Doran E, Cooke N, Jackson R, Swift J, Fitzgerald DC, Heaney LG, Fallon PG, Kissenpfennig A, Johnston JA: SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses. J Exp Med 2011, 208:1523-1531
19. Machado FS, Aliberti J: Impact of lipoxin-mediated regulation on immune response to infectious disease. Immunol Res 2006, 35:209-218
20. Chen XS, Sheller JR, Johnson EN, Funk CD: Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994, 372:179-182
21. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ, Alexander WS: Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 2000, 405:1069-1073
22. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS: Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000, 102:3003-3008
23. Roman-Campos D, Duarte HL, Sales PA Jr., Natali AJ, Ropert C, Gazzinelli RT, Cruz JS: Changes in cellular contractility and cytokines profile during Trypanosoma cruzi infection in mice. Basic Res Cardiol 2009, 104:238-246
24. Roman-Campos D, Campos AC, Gioda CR, Campos PP, Medeiros MA, Cruz JS: Cardiac structural changes and electrical remodeling in a thiamine-deficiency model in rats. Life Sci 2009, 84:817-824
25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography' S Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography; European Society of Cardiology: Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7:79-108
26. Guatimosim S, Sobie EA, dos Santos Cruz J, Martin LA, Lederer WJ: Molecular identification of a TTX-sensitive Ca(2+) current. Am J Physiol Cell Physiol 2001, 280:C1327-C1339
27. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ: Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997, 276:800-806
28. Henderson WR Jr., Chi EY: The importance of leukotrienes in mast cell-mediated Toxoplasma gondii cytotoxicity. J Infect Dis 1998, 177:1437-1443
29. Machado ER, Ueta MT, Lourenco EV, Anibal FF, Sorgi CA, Soares EG, Roque-Barreira MC, Medeiros AI, Faccioli LH: Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J Immunol 2005, 175:3892-3899
30. Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, Teixeira MM, Canetti C, Rossi MA, Cunha FQ, Silva JS: 5-Lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect 2010, 12:587-597
31. Tonelli RR, Torrecilhas AC, Jacysyn JF, Juliano MA, Colli W, Alves MJ: In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection. Parasitology 2011, 138:481-492
32. Sathler-Avelar R, Vitelli-Avelar DM, Teixeira-Carvalho A, Martins-Filho OA: Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?. Mem Inst Oswaldo Cruz 2009; 104(Suppl 1):246-251
33. Mariano FS, Gutierrez FR, Pavanelli WR, Milanezi CM, Cavassani KA, Moreira AP, Ferreira BR, Cunha FQ, Cardoso CR, Silva JS: The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 2008, 10:825-833
34. Josefowicz SZ, Lu LF, Rudensky AY: Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30:531-564
35. Stevens EA, Mezrich JD, Bradfield CA: The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 2009, 127:299-311
36. Serhan CN: Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007, 25:101-137
37. Machado FS, Aliberti J: Role of lipoxin in the modulation of immune response during infection. Int Immunopharmacol 2008, 8:1316-1319
38. Fernandez-Velasco M, Ruiz-Hurtado G, Hurtado O, Moro MA, Delgado C: TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am J Physiol Heart Circ Physiol 2007, 293:H238-H245
39. Hagiwara Y, Miyoshi S, Fukuda K, Nishiyama N, Ikegami Y, Tanimoto K, Murata M, Takahashi E, Shimoda K, Hirano T, Mitamura H, Ogawa S: SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes. J Mol Cell Cardiol 2007, 43:710-716
40. Takahashi N, Saito Y, Kuwahara K, Harada M, Tanimoto K, Nakagawa Y, Kawakami R, Nakanishi M, Yasuno S, Usami S, Yoshimura A, Nakao K: Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J Mol Cell Cardiol 2005, 38:185-192
41. Kato T, Sano M, Miyoshi S, Sato T, Hakuno D, Ishida H, Kinoshita-Nakazawa H, Fukuda K, Ogawa S: Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats. Circ Res 2000, 87:937-945